By Canadian Press

Health Canada approves 1st RSV vaccine for seniors

Aug 4, 2023 | 10:43 AM

OTTAWA — Health Canada has approved the first vaccine for respiratory syncytial virus (RSV) for adults age 60 and over.

Manufacturer GSK says the federal agency has approved its new vaccine called Arexvy.

Doctors have been calling for an RSV vaccine for seniors because although the virus is common, older people are much more likely to become severely ill and require hospitalization.

RSV season in Canada usually starts in the late fall and lasts until spring.

GSK says a randomized clinical trial showed the vaccine was 82 per cent effective at preventing lower respiratory tract disease caused by RSV compared to seniors who got a placebo.

WHAT'S ON

Here is what's on this weekend in Medicine Hat and area: Dec. 13-15

9h ago

IN THE COMMUNITY

Medicine Hat's Mustard Seed adding new shelter spaces at Alberta government's request

Dec 12, 2024

HOLIDAYS

Medicine Hat Kiwanis hosting Christmas dinner, applications due Friday

Dec 12, 2024

The company says it was 94 per cent effective at preventing the illness in seniors with underlying medical conditions.

This report by The Canadian Press was first published Aug. 4, 2023.

The Canadian Press